Ms. Syto is Director of Clinical Operations at Celgene, where she brings more than 20 years of experience in pharmaceutical development. Prior to joining Celgene, she was Senior Director of Clinical Operations at Tragara Pharmaceuticals, where she was responsible for the implementation and management of multiple Phase I and II oncology clinical trials. Prior to joining Tragara, Ms. Syto successfully led clinical teams in a variety of roles at PAREXEL International, in support of Phase II and III clinical trials for both large pharma and small company clients. Her therapeutic expertise includes dermatology, gastroenterology, immunology, neurology, oncology (hematology and solid tumors).
Ms. Syto is Director of Clinical Operations at Celgene, where she brings more than 20 years of experience in pharmaceutical development. Prior to joining Celgene, she was Senior Director of Clinical Operations at Tragara Pharmaceuticals, where she was responsible for the implementation and management of multiple Phase I and II oncology clinical trials. Prior to joining Tragara, Ms. Syto successfully led clinical teams in a variety of roles at PAREXEL International, in support of Phase II and III clinical trials for both large pharma and small company clients. Her therapeutic expertise includes dermatology, gastroenterology, immunology, neurology, oncology (hematology and solid tumors).
